CONSENSUS
1987
Cooperative North Scandinavian Enalapril Survival Study
In 253 patients with NYHA IV heart failure, enalapril reduced 6-month mortality versus placebo.
Result
- Absolute difference
- 18 points
RRR40
The absolute difference is derived from the event rates.
Also reported: Effect maintained at 12 months.
- Subtopic
- RAAS inhibition
- Design
- Double-blind RCT, terminated early
- Relevance
- Practice-defining: a trial the guidelines cite as evidence.
- Source
- CONSENSUS Trial Study Group. N Engl J Med. 1987;316(23):1429-1435.doi 10.1056/NEJM198706043162301
Discussion & critique
Small but transformative: opened the ACE inhibitor era for HF. Limited to severe HF; SOLVD generalised to milder disease.